Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions.
deep penetrating melanoma
deep penetrating nevus
immune checkpoint inhibition
malignant melanoma
mutation profiling
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
23 Aug 2022
23 Aug 2022
Historique:
received:
21
06
2022
revised:
19
07
2022
accepted:
26
07
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
10
9
2022
Statut:
epublish
Résumé
Melanocytic neoplasms have been genetically characterized in detail during the last decade. Recurrent
Identifiants
pubmed: 36077603
pii: cancers14174066
doi: 10.3390/cancers14174066
pmc: PMC9454999
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : Deutsche Forschungsgemeinschaft
ID : HO 6389/2-2
Organisme : Deutsche Forschungsgemeinschaft
ID : PA 2376/1-2
Organisme : Deutsche Forschungsgemeinschaft
ID : SCHA 422/17-2
Références
N Engl J Med. 2019 Aug 15;381(7):626-636
pubmed: 31166680
Science. 2013 Feb 22;339(6122):959-61
pubmed: 23348503
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10050-5
pubmed: 10963668
Nat Med. 2019 Dec;25(12):1916-1927
pubmed: 31792460
Mol Cells. 2019 Jan 31;42(1):8-16
pubmed: 30699286
Genome Biol. 2016 Oct 7;17(1):208
pubmed: 27717381
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Annu Rev Pathol. 2014;9:239-71
pubmed: 24460190
Nat Commun. 2017 Sep 21;8(1):644
pubmed: 28935960
Bioinformatics. 2012 May 15;28(10):1307-13
pubmed: 22474122
Ann Appl Stat. 2012 Sep;6(3):1306-1326
pubmed: 24069112
Lancet Oncol. 2018 Nov;19(11):1480-1492
pubmed: 30361170
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679
Science. 2013 Feb 22;339(6122):957-9
pubmed: 23348506
Nat Protoc. 2020 Oct;15(10):3240-3263
pubmed: 32978601
J Clin Invest. 2018 May 1;128(5):2048-2063
pubmed: 29664013
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1193-8
pubmed: 19144919
Oncol Res Treat. 2016;39(10):652-654
pubmed: 27710979
Hum Mutat. 2014 Jul;35(7):899-907
pubmed: 24599517
Virchows Arch. 2022 Feb;480(2):475-480
pubmed: 34013383
Lancet Oncol. 2017 Jul;18(7):863-873
pubmed: 28592387
Clin Cancer Res. 2018 Sep 15;24(18):4494-4504
pubmed: 29891723
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Sci Signal. 2012 Jan 10;5(206):ra3
pubmed: 22234612
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
J Immunol. 2011 Jan 15;186(2):784-90
pubmed: 21149602
J Neurooncol. 2016 May;127(3):435-44
pubmed: 26744134
Curr Oncol Rep. 2018 Sep 14;20(11):86
pubmed: 30218391
Cell. 2012 Jul 20;150(2):251-63
pubmed: 22817889
J Clin Oncol. 2018 Dec 10;36(35):3441-3449
pubmed: 30343620
Cancer Cell. 2011 Dec 13;20(6):741-54
pubmed: 22172720
Int J Cancer. 2022 Nov 1;151(9):1542-1554
pubmed: 35737508
Oral Oncol. 2017 Sep;72:165-173
pubmed: 28797453
Oncoimmunology. 2015 Aug 31;5(3):e1086862
pubmed: 27141343
Nat Methods. 2014 Nov;11(11):1138-1140
pubmed: 25262207
Genome Biol. 2017 Mar 24;18(1):55
pubmed: 28340624
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Oncotarget. 2017 Nov 24;9(4):5492-5508
pubmed: 29435196
Genome Biol. 2019 Mar 14;20(1):55
pubmed: 30871603
Nature. 2015 Jul 9;523(7559):231-5
pubmed: 25970248
J Cell Biol. 2002 Dec 9;159(5):867-80
pubmed: 12473692
Oncotarget. 2017 Jun 20;8(25):40683-40692
pubmed: 28380455
Nat Commun. 2020 Oct 27;11(1):5414
pubmed: 33110075
JAMA Oncol. 2017 Nov 01;3(11):1511-1519
pubmed: 28662232